Mefenamic Acid

We are a manufacturer based in China. We specialize in providing high-quality Mefenamic Acid for industrial clients across various sectors. Whether you need chemicals consultation or technical support, our team is here to help.

Category:Chemical Additives   Own Brand:MT  /MOQ:100KG  /From China/  B2B only.

Advantage:Customizable,Please tell me your specific needs↓↓↓

Introduction

Mefenamic Acid is an anti-inflammatory and analgesic drug with antipyretic, analgesic and anti-inflammatory effects. The analgesic effect is strong and the antipyretic effect is long-lasting, but the anti-inflammatory effect is not as good as that of Baotaisong and flufenamic acid.

1. Introduction

Mefenamic acid is a nonsteroidal anti-inflammatory drug (NSAID) belonging to the fenamate class. It is primarily used for its analgesic, anti-inflammatory, and antipyretic properties.

2. Mechanism of Action

– Inhibits cyclooxygenase (COX-1 and COX-2), reducing prostaglandin synthesis.

– Modulates pain and inflammation by blocking prostaglandin-mediated effects.

3. Therapeutic Uses

– Pain Relief: Effective for mild to moderate pain (e.g., headaches, dental pain, dysmenorrhea).

– Inflammatory Conditions: Used in rheumatoid arthritis and osteoarthritis (though less common than other NSAIDs).

– Menstrual Pain (Primary Dysmenorrhea):** One of its key indications due to strong prostaglandin inhibition.

4. Pharmacokinetics

– Absorption: Rapidly absorbed after oral administration (~50% bioavailability).

– Metabolism: Hepatic metabolism via CYP2C9.

– Excretion:Primarily renal (urine), with a half-life of **2–4 hours**.

5. Adverse Effects

– Common: GI disturbances (nausea, diarrhea, dyspepsia), dizziness, headache.

– Serious:

– GI ulcers/bleeding (higher risk than some NSAIDs).

– Renal impairment (especially in dehydrated or elderly patients).

– Hypersensitivity reactions (rash, Stevens-Johnson syndrome).

– Hepatotoxicity (rare but reported).

6. Drug Interactions

– Anticoagulants (e.g., warfarin): ↑ Bleeding risk.

– Diuretics/ACE inhibitors:Reduced efficacy due to fluid retention.

– Other NSAIDs/aspirin: ↑ GI toxicity.

7. Contraindications & Precautions

– Contraindicated in:

– Peptic ulcer disease.

– Severe renal/hepatic impairment.

– Asthma/NSAID-induced hypersensitivity.

– Use with caution in:

– Elderly patients.

– Cardiovascular disease (may ↑ BP).

8. Special Considerations

– Short-term use preferred (due to higher GI toxicity risk).

– Avoid in pregnancy (3rd trimester)—risk of premature ductus arteriosus closure.

9. Conclusion

Mefenamic acid is effective for acute pain and dysmenorrhea but carries significant GI and renal risks. Should be used at the **lowest effective dose for the shortest duration.

Basic Physicochemical Properties

Property Specification Test Method
Chemical Name 2-[(2.3-Dimethylphenyl)amino]benzoic acid IUPAC nomenclature
Molecular Formula C₁₅H₁₅NO₂ Elemental analysis
Molecular Weight 241.29 g/mol Mass spectrometry
Appearance White to pale yellow crystalline powder Visual inspection
Solubility (25°C) Practically insoluble in water, soluble in ethanol, acetone USP <911>
Melting Point 230–235°C DSC analysis

Pharmacological Profile

Parameter Value/Description Reference Standard
Mechanism of Action Non-selective COX inhibitor FDA label
Bioavailability ~90% (oral) Clinical studies
Half-life (t₁/₂) 2–4 hours Pharmacokinetic data
Protein Binding >90% In vitro studies
Metabolism Hepatic (CYP2C9-mediated) EMA assessment report

Therapeutic Applications & Dosage

Medical Condition Recommended Dosage Maximum Daily Dose
Mild to moderate pain 500 mg initial dose, then 250 mg every 6h 1.500 mg
Primary dysmenorrhea 500 mg loading dose, then 250 mg every 6h 1.500 mg
Rheumatoid arthritis 250–500 mg three times daily 1.500 mg

Pharmacopoeial Compliance

Standard Requirement Compliance Status
USP-NF Meets monograph standards Compliant
Ph. Eur. Conforms to EP 10.0 Compliant
BP 2023 Meets British Pharmacopoeia Compliant
ICH Q3D (Impurities) Heavy metals <20 ppm Compliant
Residual Solvents Class 2/3 limits per ICH Q3C Compliant

Stability & Storage Conditions

Parameter Specification
Storage temperature 15–30°C (controlled room temp)
Shelf life 36 months (unopened)
Light sensitivity Protect from light
Packaging HDPE bottles with desiccant
Regulatory status FDA/EMA-approved prescription drug

,Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.

If you're ready to take the next step, Leave your message below and we’ll reply soon. 20+ years of chemical manufacturing & export experience, a partner you can trust.

Inquiry

                               

    Factory & Shipment

    chemical factory
    chemical factory
    Powder Coatings
    chemical factory